Package 0069-1501-30

Brand: talzenna

Generic: talazoparib
NDC Package

Package Facts

Identity

Package NDC 0069-1501-30
Digits Only 0069150130
Product NDC 0069-1501
Product ID 0069-1501_e189da1b-d503-48a4-aba3-4f93a3fab2d3
Description

1 BOTTLE in 1 CARTON (0069-1501-30) / 30 CAPSULE in 1 BOTTLE

Marketing

Marketing Status
Discontinued 2027-03-31
Brand talzenna
Generic talazoparib
Sample Package No

Linked Drug Pages (1)

Talzenna ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "e189da1b-d503-48a4-aba3-4f93a3fab2d3", "openfda": {"unii": ["02WK9U5NZC"], "rxcui": ["2099946", "2099952", "2099954", "2099956", "2591510", "2591512", "2591520", "2591521", "2639960", "2639962", "2639964", "2639966"], "spl_set_id": ["f2423edd-6d24-495c-aec1-c2f457f08d9a"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (0069-1501-30)  / 30 CAPSULE in 1 BOTTLE", "package_ndc": "0069-1501-30", "marketing_end_date": "20270331", "marketing_start_date": "20220131"}], "brand_name": "Talzenna", "product_id": "0069-1501_e189da1b-d503-48a4-aba3-4f93a3fab2d3", "dosage_form": "CAPSULE", "pharm_class": ["Poly(ADP-Ribose) Polymerase Inhibitor [EPC]", "Poly(ADP-Ribose) Polymerase Inhibitors [MoA]"], "product_ndc": "0069-1501", "generic_name": "talazoparib", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Talzenna", "active_ingredients": [{"name": "TALAZOPARIB TOSYLATE", "strength": ".5 mg/1"}], "application_number": "NDA211651", "marketing_category": "NDA", "marketing_end_date": "20270331", "marketing_start_date": "20220131"}